{"id":"https://openalex.org/W4310127384","doi":"https://doi.org/10.1182/blood-2022-156660","title":"Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma","display_name":"Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310127384","doi":"https://doi.org/10.1182/blood-2022-156660"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-156660","doi":"https://doi.org/10.1182/blood-2022-156660","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-156660","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085820043","display_name":"Timothy J. Voorhees","orcid":"https://orcid.org/0000-0001-7603-6454","observed_orcids":["https://orcid.org/0000-0001-7603-6454"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J. Voorhees","raw_affiliation_strings":["1James Comprehensive Cancer Center, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1James Comprehensive Cancer Center, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086211539","display_name":"Anne Beaven","orcid":"https://orcid.org/0000-0002-9174-3568","observed_orcids":["https://orcid.org/0000-0002-9174-3568"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne W. Beaven","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077127349","display_name":"Christopher E. Dittus","orcid":"https://orcid.org/0000-0002-9794-7908","observed_orcids":["https://orcid.org/0000-0002-9794-7908"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Dittus","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035811418","display_name":"George Hucks","orcid":"https://orcid.org/0000-0002-4515-7277","observed_orcids":["https://orcid.org/0000-0002-4515-7277"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George E Hucks","raw_affiliation_strings":["3Division of Pediatric Hematology/Oncology and Bone Marrow Transplant, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Pediatric Hematology/Oncology and Bone Marrow Transplant, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091401985","display_name":"J. Kaitlin Morrison","orcid":"https://orcid.org/0009-0007-1298-3728","observed_orcids":["https://orcid.org/0009-0007-1298-3728"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Kaitlin Morrison","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102818653","display_name":"Catherine Joyce Arago Cheng","orcid":"https://orcid.org/0000-0002-1619-9320","observed_orcids":["https://orcid.org/0000-0002-1619-9320"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Joyce Arago Cheng","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053627919","display_name":"Tammy Cavallo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tammy Cavallo","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904385","display_name":"Steven I. Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven I. Park","raw_affiliation_strings":["4Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023649972","display_name":"Gianpietro Dotti","orcid":"https://orcid.org/0000-0002-2639-8526","observed_orcids":["https://orcid.org/0000-0002-2639-8526"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gianpietro Dotti","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026510629","display_name":"Jonathan Stuart Serody","orcid":"https://orcid.org/0000-0003-4568-1092","observed_orcids":["https://orcid.org/0000-0003-4568-1092"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan S. Serody","raw_affiliation_strings":["5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065544223","display_name":"Barbara Savoldo","orcid":"https://orcid.org/0000-0002-7571-3887","observed_orcids":["https://orcid.org/0000-0002-7571-3887"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Savoldo","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075085884","display_name":"Natalie Sophia Grover","orcid":"https://orcid.org/0000-0002-1346-3157","observed_orcids":["https://orcid.org/0000-0002-1346-3157"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie S. Grover","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.4146,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.60034378,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"12723","last_page":"12724"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.09719999879598618,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-hodgkin-lymphoma","display_name":"relapsed/refractory Hodgkin lymphoma","score":0.796999990940094},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/car-t-cell-persistence","display_name":"CAR T cell persistence","score":0.6179999709129333},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2911194787","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"CAR T-cell therapy","level":5,"score":0.6699469089508057},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6696749925613403},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5953305959701538},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5109690427780151},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.502180814743042},{"id":"https://openalex.org/C70905583","wikidata":"https://www.wikidata.org/wiki/Q3648608","display_name":"CD30","level":3,"score":0.4994227886199951},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48448869585990906},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2440391480922699},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15625718235969543},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.14153996109962463}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-156660","doi":"https://doi.org/10.1182/blood-2022-156660","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-156660","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2986674840","https://openalex.org/W3044350523","https://openalex.org/W2913908221","https://openalex.org/W4310106518","https://openalex.org/W4406319028","https://openalex.org/W4220882036","https://openalex.org/W4405047656","https://openalex.org/W7134117006","https://openalex.org/W4361270078","https://openalex.org/W2910288910"],"abstract_inverted_index":{"Background:":[0],"Anti-CD30":[1],"chimeric":[2],"antigen":[3],"receptor":[4],"(CD30.CAR)":[5],"T-cell":[6],"therapy":[7,104,136,150,231,261,323,326,355,384,439,443,504,646],"has":[8,47],"been":[9,48,64],"studied":[10,65],"in":[11,66,70,111,157,172,265,271,277,365,370,407,415,421,430,483,530,655],"heavily":[12],"pretreated":[13],"relapsed/refractory":[14],"(r/r)":[15],"classic":[16],"Hodgkin":[17],"lymphoma":[18],"(cHL)":[19],"patients":[20,71,112,127,190,217,237,247,289,298,305,337,348,367,377,405,436,473,491,571,599,607,656],"with":[21,50,72,75,113,128,193,301,308,359,392,461,492,572,588,608,657],"an":[22,350,408],"objective":[23,351],"response":[24,31,43,110,257,269,352,362,590],"rate":[25,33],"(ORR)":[26],"of":[27,34,54,98,109,125,140,169,206,216,227,230,283,293,313,334,363,374,399,448,458,466,485,499,514,521,553,570],"62%":[28],"and":[29,60,80,105,120,146,167,187,245,274,303,368,417,509,592],"complete":[30],"(CR)":[32],"51%":[35],"(Ramos":[36],"et":[37],"al,":[38],"JCO,":[39],"2020).":[40],"Despite":[41],"high":[42,589],"rates,":[44],"disease":[45,276],"progression":[46,82,284],"observed,":[49],"a":[51,239,249,263,360,380,462],"1-year":[52],"PFS":[53,426],"36%.":[55],"The":[56,213,224,255,317,424],"anti-PD-1":[57,99,115,149,295,325,340,354,383,393,438,503,522,559,578,604,611,626,639,645],"antibodies":[58],"nivolumab":[59],"pembrolizumab":[61,309],"have":[62,576],"both":[63],"phase":[67],"II":[68],"studies":[69],"r/r":[73,129,573],"cHL":[74,574],"ORR":[76],"ranging":[77,86],"between":[78],"65-87%":[79],"median":[81,214,225,318,425,463],"free":[83],"survival":[84],"(PFS)":[85],"from":[87,179,320],"13-15":[88],"months.":[89],"Limited":[90],"data":[91,459,642],"is":[92,566,618,631],"available":[93,482,548],"regarding":[94],"the":[95,106,122,138,281,314,335,375,397,400,456,486,531,567,619],"clinical":[96,123,208],"benefit":[97],"therapies":[100,579],"following":[101,285,502,625],"CD30.CAR-T":[102,134,170,195,286,500,515,540,554,581,623,636],"cell":[103,135,243,253,260,287,322,344,388,442,516,541,555,582],"potential":[107],"mechanism":[108],"prior":[114,228,240,250,339,385,601,610],"exposure.":[116],"Methods:":[117],"We":[118],"followed":[119],"analyzed":[121],"outcome":[124],"10":[126,336,347,487],"HL":[130],"who":[131,378,575],"progressed":[132],"after":[133,356,440,519,539,558,580,638],"at":[137,143,535],"University":[139],"North":[141],"Carolina":[142],"Chapel":[144],"Hill":[145],"subsequently":[147],"received":[148,577],"to":[151,258,324,353,382,386,446,549,603,621,633],"treat":[152],"relapsed":[153],"disease.":[154],"Clinical":[155,584],"responses":[156],"follow":[158,402,464],"up":[159,465],"were":[160,191,290,299,306,474,481,546],"determined":[161,175],"per":[162],"local":[163],"radiologist":[164],"assessment.":[165],"Expansion":[166],"persistence":[168,498],"cells":[171,196,201,501],"vivo":[173],"was":[174,218,232,262,327,427],"by":[176],"quantitative":[177],"PCR":[178,528],"peripheral":[180,478,532],"blood":[181,479,533],"samples.":[182],"Results:":[183],"Between":[184],"October":[185],"2016":[186],"November":[188],"2019,":[189],"treated":[192,300,307],"either":[194],"(9":[197],"patients)":[198],"or":[199],"CD30.CCR4.CAR-T":[200],"(1":[202],"patient)":[203],"on":[204,311],"one":[205],"three":[207],"trials":[209],"(NCT02690545,":[210],"NCT02663297,":[211],"NCT03602157).":[212],"age":[215],"30":[219],"years":[220,420,468],"(range,":[221,234,330,469],"24-51":[222],"years).":[223],"number":[226],"lines":[229],"8":[233,404],"5-16).":[235],"Eight":[236,297],"had":[238,248,338,349,379,511,526,600],"autologous":[241],"stem":[242,252],"transplant,":[244],"six":[246],"allogeneic":[251],"transplant.":[254],"best":[256,361],"CAR-T":[259,321,343,357,387,441],"CR":[264,364,391],"5":[266],"patients,":[267],"partial":[268],"(PR)":[270],"1":[272,413,450,537],"patient,":[273],"stable/progressive":[275],"4":[278],"patients.":[279,372,423,488],"At":[280,396,455],"time":[282,319,398,457],"therapy,":[288,449],"offered":[291],"standard":[292],"care":[294],"therapy.":[296,345,523,560,605,627],"nivolumab,":[302],"2":[304],"based":[310],"decision":[312],"treating":[315],"physician.":[316],"171":[328],"days":[329],"56-858":[331],"days).":[332],"Seven":[333],"exposure":[341,602,612],"before":[342],"All":[346,489,606],"cells,":[358,651],"7":[366,416],"PR":[369,381],"3":[371,419,422,484,490],"Four":[373],"6":[376],"treatment,":[389],"achieved":[390],"re-challenge":[394],"afterwards.":[395],"last":[401],"up,":[403],"remain":[406],"ongoing":[409,452],"response,":[410],"lasting":[411],"over":[412,418],"year":[414,538],"not":[428,547],"reached":[429],"this":[431,565],"cohort":[432,569],"(Fig":[433,505],"1A).":[434],"Five":[435],"stopped":[437],"(4":[444],"related":[445],"toxicity":[447],"for":[451,551,635],"durable":[453,593,614],"response).":[454],"collection,":[460],"3.6":[467],"1.7-4.7":[470],"years),":[471],"all":[472],"still":[475],"alive.":[476],"Longitudinal":[477],"samples":[480,494],"longitudinal":[493],"demonstrated":[495],"expansion":[496,513,552,624],"and/or":[497],"1B).":[506],"Patient":[507,524],"#9":[508],"#5":[510],"impressive":[512],"signals":[517,529,556],"shortly":[518,557],"start":[520],"#1":[525],"detectable":[527],"until":[534],"least":[536],"infusion;":[542],"however,":[543],"sample":[544],"timepoints":[545],"assess":[550,634],"Conclusion:":[561],"To":[562],"our":[563,641],"knowledge,":[564],"largest":[568],"treatment.":[583],"efficacy":[585],"appears":[586],"strong,":[587],"rates":[591],"remissions":[594],"observed":[595],"even":[596],"if":[597],"most":[598],"no":[609],"experienced":[613],"remissions.":[615],"This":[616],"study":[617],"first":[620],"describe":[622],"While":[628],"further":[629,653],"analysis":[630],"warranted":[632],"functionality":[637],"exposure,":[640],"suggest":[643],"that":[644],"may":[647],"rescue":[648],"CD30.CAR":[649],"T":[650],"supporting":[652],"investigations":[654],"cHL.":[658],"Figure":[659],"1View":[660,663],"largeDownload":[661,664],"PPTFigure":[662],"PPT":[665],"Close":[666],"modal":[667]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-11-30T00:00:00"}